Gene-editing stocks are shares of biotechnology companies that focus on modifying DNA.
Gene-editing companies using CRISPR technology have the potential to treat and even cure diseases caused by genetic variants. CRISPR (pronounced “crisper”) is an acronym for Clustered Regularly Interspaced Short Palindromic Repeats. The gene-editing market is projected to reach $30.8 billion by 2032.
These are some of the gene-editing companies investors should have on their watch list.
This post originally appeared at The Motley Fool.